Which mutual funds hold Procter & Gamble Health Limited?

19 mutual funds hold Procter & Gamble Health Limited as of Sep 2026. The highest weight is 4.03% held by UTI - MNC Fund - Growth Option - Direct. Data from official AMFI monthly portfolio disclosures.

What sector is Procter & Gamble Health Limited in?

Procter & Gamble Health Limited is in the Pharmaceuticals & Biotechnology sector and is categorised as by SEBI.

What is the SEBI market cap category of Procter & Gamble Health Limited?

As per SEBI and AMFI classification (Jan-Jun 2026), Procter & Gamble Health Limited is a Small Cap stock ranked #585 with an average market cap of ₹8.92 K Cr.

Pharmaceuticals & Biotechnology

Procter & Gamble Health Limited

ISIN: INE199A01012 · Data as of Sep 2026

Share: WhatsApp ✕ X

Search another stock:

Active Funds Holding

vs Last Month

0 funds

Total Value

₹809.01 Cr

Avg Weight

1.89%

New Entries

Exits

Top Holder

UTI - MNC Fund - Growth Option - Direct 4.03%

ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.

Small Cap Rank #585

₹7.84 K Cr

Avg Mkt Cap · Jan-Jun 2023 (3yr ago)

→

₹8.92 K Cr

Avg Mkt Cap · Jan-Jun 2026 (latest)

+13.8%

3yr change

SEBI · AMFI Market Cap List

📋 What Changed This Month Procter & Gamble Health Limited is currently held by 19 active mutual funds with total exposure of ₹809.01 Cr. This month 0 funds entered and 0 funds exited. UTI - MNC Fund - Growth Option - Direct has the highest allocation at 4.03%. ↓ Scroll down for full fund list and monthly changes.

Trend

How Has Fund Coverage Changed — Last 5 Months?

Month	Funds	AUM (Cr)	AMCs	Status
Sep 2026 REFERENCE	19	₹809	48 / 49
Aug 2026	19	₹833	49 / 49	✅ Complete
Jul 2026	19	₹946	49 / 49	✅ Complete
Jun 2026	19	₹946	49 / 49	✅ Complete
May 2026	20	₹949	49 / 49	✅ Complete

📌 Portfolio changes below are based on Sep 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Sep 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (0)

No new entries this month

▼ Exits (0)

No exits this month

↑ Increased (10)

UTI - MNC Fund - Growth Option - Direct +0.1%

Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth +0.04%

Tata India Pharma & Healthcare Fund-Direct Plan-Growth +0.24%

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth +0.01%

Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth +0.01%

Aditya Birla Sun Life MNC Fund - Growth - Direct Plan +0.08%

Aditya Birla Sun Life Business Cycle Fund-Direct Growth +0.03%

BAJAJ FINSERV SMALL CAP FUND - DIRECT - GROWTH +0.11%

↓ Decreased (7)

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth -0.01%

DSP Healthcare Fund - Direct Plan - Growth -0.04%

UTI Healthcare Fund - Direct Plan - Growth Option -0.05%

ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND -0.02%

WhiteOak Capital Pharma and Healthcare Fund -0.07%

Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option -0.01%

Baroda BNP Paribas Health and Wellness Fund Direct Growth -0.4%

By Category

Which Fund Categories Hold This Stock?

Category	Funds	Avg Weight	Distribution
Equity	17	2.05%
Small Cap	2	0.61%

All Holdings

Which 19 Active Funds Hold Procter & Gamble Health Limited?

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
UTI - MNC Fund - Growth Option - Direct UTI Mutual Fund	Equity	4.03%	₹105.63 Cr	+0.1%
Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	3.19%	₹68.87 L	+0.04%
Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	2.88%	₹97.24 L	—
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth Sundaram Mutual Fund	Equity	2.85%	₹1.02 Cr	-0.01%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth Sundaram Mutual Fund	Equity	2.84%	₹87.51 L	—
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Tata Mutual Fund	Equity	2.75%	₹41.50 Cr	+0.24%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	2.71%	₹2.03 Cr	+0.01%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	2.66%	₹95.02 L	+0.01%
DSP Healthcare Fund - Direct Plan - Growth DSP Mutual Fund	Equity	2.36%	₹88.61 Cr	-0.04%
UTI Healthcare Fund - Direct Plan - Growth Option UTI Mutual Fund	Equity	1.95%	₹27.82 Cr	-0.05%
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND Aditya Birla Sun Life Mutual Fund	Equity	1.82%	₹19.58 Cr	-0.02%
Aditya Birla Sun Life MNC Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund	Equity	1.74%	₹52.69 Cr	+0.08%
WhiteOak Capital Pharma and Healthcare Fund WhiteOak Capital Mutual Fund	Equity	1.18%	₹10.89 Cr	-0.07%
Aditya Birla Sun Life Business Cycle Fund-Direct Growth Aditya Birla Sun Life Mutual Fund	Equity	0.92%	₹15.79 Cr	+0.03%
BAJAJ FINSERV SMALL CAP FUND - DIRECT - GROWTH Bajaj Finserv Mutual Fund	Small Cap	0.73%	₹20.09 Cr	+0.11%
Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund	Small Cap	0.48%	₹386.44 Cr	-0.01%
Aditya Birla Sun Life Consumption Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund	Equity	0.43%	₹24.76 Cr	+0.01%
Tata India Consumer Fund-Direct Plan-Growth Tata Mutual Fund	Equity	0.29%	₹7.83 Cr	+0.01%
Baroda BNP Paribas Health and Wellness Fund Direct Growth Baroda BNP Paribas Mutual Fund	Equity	0.17%	₹85.28 L	-0.4%

Explore More

← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.